Sell:$6.30Buy:$17.60$0.34 (2.09%)
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
15 October 2024 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTDPublic Company | Sell Regular sell transaction (market) | 2,300 | $13.02 | $29,946.00 | 64,167 |
14 October 2024 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTDPublic Company | Sell Regular sell transaction (market) | 1,300 | $13.12 | $17,056.00 | 66,467 |
11 October 2024 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTDPublic Company | Sell Regular sell transaction (market) | 1,580 | $13.37 | $21,124.60 | 67,767 |
10 October 2024 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTDPublic Company | Sell Regular sell transaction (market) | 3,000 | $13.39 | $40,170.00 | 69,347 |
9 October 2024 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTDPublic Company | Sell Regular sell transaction (market) | 1,816 | $13.36 | $24,261.76 | 72,347 |
8 October 2024 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTDPublic Company | Sell Regular sell transaction (market) | 1,800 | $13.13 | $23,634.00 | 74,163 |
1 October 2024 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTDPublic Company | Sell Regular sell transaction (market) | 1,399 | $13.54 | $18,942.46 | 75,963 |
6 September 2024 | Jonathan David LanoyChief Accounting Officer | Sell Tax related | 2,653 | $13.05 | $34,621.65 | 47,343 |
21 July 2024 | Terrence MooreheadPresident/CEO | Sell Tax related | 9,313 | $15.55 | $144,817.15 | 509,385 |
21 July 2024 | Bryant J. YatesOther President | Sell Tax related | 1,553 | $15.55 | $24,149.15 | 97,299 |
Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
---|---|---|---|---|---|---|
30 November 2023 | Daniel C (Dan) NormanOther President | Sell Regular sell transaction (market) | 13,000 | $17.06 | $221,780.00 | 54,765 |
20 April 2024 | Terrence MooreheadPresident/CEO | Sell Tax related | 9,560 | $19.29 | $184,412.40 | 518,698 |
21 July 2024 | Terrence MooreheadPresident/CEO | Sell Tax related | 9,313 | $15.55 | $144,817.15 | 509,385 |
19 December 2023 | Leslie Shane JonesCFO | Sell Tax related | 5,965 | $17.70 | $105,580.50 | 85,875 |
29 March 2024 | Terrence MooreheadPresident/CEO | Sell Tax related | 4,157 | $20.77 | $86,340.89 | 528,258 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.